• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to footer
BlackDoctor.org
Where Wellness & Culture Connect

Where Wellness & Culture Connect

  • Conditions
  • Wellness
  • Lifestyle
  • Longevity
  • Clinical Trials
  • Resources
    • Generational Health
    • Top Blacks in Healthcare 2025
    • Hall Of Fame
    • Clinical Trials Resource Center
    • Obesity Resource Center
    • Cancer Resource Center
    • Wellness on the Yard
    • Immunocompromised Care
    • BDO Resource Library
  • Find A Doctor
  • BDO TV
Home / Health Conditions / Clinical Trials / Why Aren’t More Men Participating in Lifesaving Clinical Trials?

Why Aren’t More Men Participating in Lifesaving Clinical Trials?

Why Aren't More Men Participating in Lifesaving Clinical Trials?

A recent study has shed light on a persistent problem in health research: the underrepresentation of men in behavioral clinical trials, particularly those focused on lifestyle interventions. The research, published in Trials, looked at data from the Enhanced Lifestyles for Metabolic Syndrome (ELM) trial, a behavioral clinical trial targeting lifestyle change and remission of metabolic syndromes like obesity and high blood pressure, to investigate factors associated with male recruitment. The findings underscore the need for tailored recruitment strategies that address the specific reasons why men may be less likely to participate in such studies.

Metabolic syndrome, a cluster of conditions that increase the risk of heart disease, stroke, and diabetes, affects a significant portion of the population. Lifestyle changes, including diet and exercise, are crucial for managing and even reversing this condition. Behavioral clinical trials play a vital role in developing and evaluating effective interventions. However, the lack of male participation in these trials can limit how far these interventions go in preventing disease.

Key Findings and Implications

One of the most significant findings of the study was that men were more likely to drop out of the recruitment process at earlier stages compared to women. Specifically, a smaller proportion of men (58.3%) attended the in-person information session compared to women (66.5%). This suggests that initial engagement and interest are critical factors in male recruitment. Once men attended the information session, the proportion that moved forward through the remaining screening steps was similar to women, indicating that the primary challenge lies in capturing their initial interest and getting them to engage with the study in the first place.

You May Also Like
Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here. Psoriatic Arthritis Can Feel Beyond Your Control. Consider a Different Direction. Learn More Here.

This finding has important implications for recruitment strategies. It suggests that efforts to increase male enrollment should focus on enhancing initial outreach and communication. This could involve using different communication channels, tailoring messaging to resonate with men’s specific concerns and motivations, and making the initial steps of the recruitment process as easy and accessible as possible.

Another key finding was the association between self-awareness of health risk and participation among men. The study suggests that men who were more aware of their own health risks were more likely to express interest in the trial. This highlights the importance of raising awareness about metabolic syndrome and its associated risks among men. Public health campaigns and targeted outreach efforts could play a crucial role in increasing men’s understanding of their health status and motivating them to seek out and participate in relevant research.

Tailoring recruitment efforts to the specific needs and interests of each sex is essential for maximizing participation. This could involve using different messaging, targeting different communication channels, and offering different types of incentives.

You May Also Like
Get GLP-1s Delivered to You As Low As $99/Month! Get GLP-1s Delivered to You As Low As $99/Month!

Recommendations for Future Research and Practice

Based on these findings, the researchers recommend several key strategies for improving male recruitment in behavioral clinical trials:

  • Focus on early engagement: Prioritize strategies that enhance initial interest and engagement among men. This could involve using targeted advertising, social media campaigns, and partnerships with community organizations that serve men.
  • Raise awareness of health risks: Implement public health campaigns and targeted outreach efforts to increase men’s awareness of metabolic syndrome and its associated risks.
  • Tailor recruitment strategies: Develop sex-specific recruitment strategies that address the unique needs and motivations of men and women.
  • Simplify the recruitment process: Make the initial steps of the recruitment process as easy and accessible as possible to minimize barriers to participation.

By addressing these challenges and implementing targeted recruitment strategies, researchers can improve male representation in behavioral clinical trials, leading to more generalizable findings and the development of more effective interventions for men’s health. This study serves as a valuable reminder that understanding the specific factors influencing participation among different demographic groups is crucial for conducting rigorous and impactful health research.

By Team BlackDoctor.org | Published August 7, 2025

August 7, 2025 by Team BlackDoctor.org

The Latest In Clinical Trials

clinical trial recruitment

How Social Media and AI Are Transforming Clinical Trial Recruitment

Lupus continues to affect racial and ethnic minority groups at disproportionately high rates, yet these same communities remain significantly underrepresented in clinical trials. Recognizing this critical gap, Lupus Therapeutics, through its Lupus Clinical Investigators Network (LuCIN), is leading research on read more about How Social Media and AI Are Transforming Clinical Trial Recruitment
This Clinical Trial Reversed a Rare Cause of Vision Loss

This Clinical Trial Reversed a Rare Cause of Vision Loss

Gene therapy may restore vision to children and adults robbed of their sight by a rare inherited condition called Leber congenital amaurosis, researchers report. The illness is caused by mutations in the GUCY2D gene, which is critical to producing proteins read more about This Clinical Trial Reversed a Rare Cause of Vision Loss
This AI Tool Detects Diabetic Eye Disease Faster in Black Americans

This AI Tool Detects Diabetic Eye Disease Faster in Black Americans

Despite the challenges of living with diabetes, a new AI-driven detection tool can help ease the burden of the disease. Researchers from Johns Hopkins Medicine and the University of Wisconsin-Madison have published a study on the use of autonomous artificial read more about This AI Tool Detects Diabetic Eye Disease Faster in Black Americans
Why I Did a Trial for TNBC: "It Very Likely Saved And Extended My Life"

Why I Did Clinical Trials for TNBC: “It Very Likely Saved And Extended My Life”

My cancer journey began in 2015 during a routine mammogram that revealed a mass in my breast, which turned out to be Triple-Negative Breast Cancer (TNBC), a rare and aggressive form of the disease. In my 50s and coming from read more about Why I Did Clinical Trials for TNBC: “It Very Likely Saved And Extended My Life”
lupus research

How Patients Are Driving Breakthroughs in Lupus Research

The Lupus Research Alliance (LRA), which formed and administers the Lupus Accelerating Breakthroughs Consortium (Lupus ABC)—a public-private partnership with the U.S. Food and Drug Administration (FDA)—is leading efforts to ensure that the voices of people living with lupus are central read more about How Patients Are Driving Breakthroughs in Lupus Research
Understanding Parkinson's Disease Clinical Trials for Black Americans

Understanding Parkinson’s Disease Clinical Trials for Black Americans

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world, after Alzheimer’s disease. Currently, nearly one million people in the United States have been diagnosed with Parkinson’s and that number is expected to further increase as the read more about Understanding Parkinson’s Disease Clinical Trials for Black Americans

Primary Sidebar

Subscribe to our newsletter

Icon

Caring for You, Too - Caregiver Workbook

1 file(s) 297 KB
Download

Trending Articles

Key Nutritional Supplements for Those Living with HIV

nutritional supplements for HIV

Why I Did Clinical Trials for TNBC: “It Very Likely Saved And Extended My Life”

Why I Did a Trial for TNBC: "It Very Likely Saved And Extended My Life"

This Clinical Trial Reversed a Rare Cause of Vision Loss

This Clinical Trial Reversed a Rare Cause of Vision Loss

This AI Tool Detects Diabetic Eye Disease Faster in Black Americans

This AI Tool Detects Diabetic Eye Disease Faster in Black Americans

Gluten Allergy Symptoms: 13 Warning Signs You Shouldn’t Ignore

gluten allergy
Find a Culturally Sensitive Doctor

Footer

Where Wellness & Culture Connect

BDO is the world’s largest and most comprehensive online health resource specifically targeted to African Americans. BDO understands that the uniqueness of Black culture - our heritage and our traditions - plays a role in our health. BDO gives you access to innovative new approaches to the health information you need in everyday language so you can break through the disparities, gain control and live your life to its fullest.

Connect With Us

Resource Centers

  • Top Blacks in Healthcare
  • Clinical Trials
  • Wellness on the Yard
  • Cancer
  • Immunocompromised Care
  • About Us
  • Privacy Policy
  • Cookie Policy
  • Terms of Service
  • Careers
  • Advertise With Us
  • Advertising & Sponsorship Policy
  • Daily Vitamina
  • TBH

Copyright © 2025, Black Doctor, Inc. All rights reserved.